Current Enterprise Value (EV)
Current share price (P) | $231.12 |
No. shares of common stock outstanding | 300,237,694 |
US$ in thousands | |
Common equity (market value)1 | 69,390,936) |
Add: Preferred stock, $.01 par value; none issued (per books) | —) |
Add: Noncontrolling interest (per books) | 10,000) |
Total equity | 69,400,936) |
Add: Notes payable (per books) | 72,100) |
Add: Convertible notes (per books) | —) |
Add: Long-term debt, excluding current maturities (per books) | 2,085,300) |
Total equity and debt | 71,558,336) |
Less: Cash and equivalents | 4,911,400) |
Less: Short-term investments | 55,000) |
Enterprise value (EV) | 66,591,936) |
Based on: 10-K (reporting date: 2014-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 231.12 × 300,237,694
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Allergan Inc. Annual Report.
3 2014 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 231.12 × 300,237,694
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Allergan Inc. EV increased from 2012 to 2013 and from 2013 to 2014. |